SCHEMBL6414554

SCHEMBL6414554

COC(=O)NC(CCN1CCC2(CC1)CCN(Cc1ccc(OC)cc1)C2=O)c1cccc(Cl)c1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 2/20 0.42
ROCK1 Q13464 2/20 0.42
CCR5 P51681 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
DRD4 P21917 2/20 0.39
LMNA P02545 1/20 0.39
KCNH2 Q12809 3/20 0.39
ALDH1A1 P00352 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
MMP1 P03956 1/20 0.39
MMP9 P14780 1/20 0.39
MMP13 P45452 1/20 0.39
ADAM17 P78536 1/20 0.39
MAPT P10636 1/20 0.39
THRB P10828 1/20 0.39
OPRM1 P35372 1/20 0.38
OPRK1 P41145 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6414551 0.99 ROCK2 (0.42) ROCK2ROCK1CCR5MEN1KMT2A
SCHEMBL6409742 0.95 ROCK2 (0.47) ROCK2ROCK1CCR5DRD4LMNA
Hydrochloric Acid SCHEMBL6409741 0.94 ROCK2 (0.46) ROCK2ROCK1CCR5DRD4LMNA
SCHEMBL6409153 0.94 MEN1 (0.42) ROCK2ROCK1CCR5MEN1KMT2A
SCHEMBL6409348 0.93 ROCK2 (0.40) ROCK2ROCK1CCR5MEN1KMT2A
Hydrochloric Acid SCHEMBL6409150 0.93 MEN1 (0.41) ROCK2ROCK1CCR5MEN1KMT2A
SCHEMBL6410427 0.92 ROCK2 (0.41) ROCK2ROCK1CCR5MEN1KMT2A
SCHEMBL6417273 0.92 HDAC11 (0.37) ROCK2ROCK1CCR5DRD4LMNA
Hydrochloric Acid SCHEMBL6408691 0.91 ROCK2 (0.41) ROCK2ROCK1CCR5MEN1KMT2A
Hydrochloric Acid SCHEMBL6408972 0.91 ROCK2 (0.41) ROCK2ROCK1CCR5MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050075326-A1 Spiro compounds and methods for the modulation of chemokine receptor activity VIROCHEM PHARMA INC (CA) 2005-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050075326-A1 Spiro compounds and methods for the modulation of chemokine receptor activity CXCR1, CXCR4, CXCR2 ROCK2 1735/4885ROCK1 1002/4885CCR5 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.